Home › NDC Lookup › Ingredients › Calcium Polycarbophil › 69846-0000-27
Equalactin Laxative Calcium polycarbophil 625 mg Tablet, 48-count — NDC 69846-0000-27 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Equalactin Laxative Calcium polycarbophil 625 mg Tablet, 48-count — NDC 69846-000-27 (Billing 69846-0000-27)

by NUMARK BRANDS, INC · 4 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK

This is a package of 48 tablets of Equalactin Laxative Calcium polycarbophil 625 mg Tablet from NUMARK BRANDS, INC, marketed since Nov 1986 and currently FDA-listed.

NDC 69846-0000-27
🏷️ FDA NDC (as labeled) 69846-000-27 billing pads the product segment with a zero
This package
Contains48-count Pack sizes2 compare ↓
Product page 69846-0000-26 Also comes in: 24 tablets 69846-000-26
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 69846-000-27
Product NDC 69846-000
11-digit billing NDC 69846000027
RxCUI 210659, 308933
UNII 8F049NKY49
Application # M007
SPL Set ID 2feed33a-3b7f-11c6-6e62-c99150ecfddd
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1986-11-21
Route ORAL
Dosage form TABLET
Substance CALCIUM POLYCARBOPHIL
Quick answers
  • RxCUI (RxNorm): 210659
Why two NDCs? The FDA registers this code as 69846-000-27 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 69846-0000-27. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Bulk-forming laxatives class.

Drug family (ATC) Bulk-forming laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

Equalactin Laxative is an over-the-counter oral tablet that contains calcium polycarbophil, a bulk-forming agent. Calcium polycarbophil is commonly used to relieve occasional constipation and to manage diarrhea by absorbing water in the intestines and helping to form stool. This product is marketed as an OTC monograph drug, meaning it follows established FDA rules for its category rather than undergoing individual product review.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 24 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
69846-0000-26 69846-000-26 Main listing 2 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK 1986-11-21 — Discontinued by firm
69846-0000-27 You're viewing this 4 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK 1986-11-21 — Active

Pack size FAQ

What quantity is in this package?
This is a 48-count package — 4 blister pack in 1 carton / 12 tablet in 1 blister pack.
How does this package differ from NDC 69846-0000-26?
Both are Equalactin Laxative Calcium polycarbophil 625 mg Tablet — the drug itself is identical. This page's package is the 48-count one, while NDC 69846-0000-26 is the 24 tablets package.
What NDC number is used to bill for this package of Equalactin Laxative Calcium polycarbophil 625 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fiber Lax 625 mg 00536-4306-05 Rugby 500 tablets $0.059 — Availability likely —
Foster and Thrive Fiber Laxative 147 625 mg 70677-1083-01 Strategic 90 tablets $0.059 — Availability likely —
Calcium Polycarbophil 625 mg 70000-0067-01 LEADER/ 250 tablets $0.059 — Availability likely —
Fiber caplets 147 625 mg 83324-0131-90 Chain 90 tablets $0.059 — Availability likely —
Fiber Tabs 625 mg 00904-2500-91 Major 90 tablets $0.059 — Availability likely —
Equalactin Laxative 625 mgthis 69846-0000-27 NUMARK 48 tablets — — FDA listed —
Fiber Laxative 625 mg 54257-0379-07 Magno-Humphries, 90 tablets — — FDA listed —
Fiber Laxative 625 mg 54257-0479-07 Magno-Humphries, 90 tablets — — FDA listed —
Calcium Polycarbophil 625 mg 70369-0006-08 CITRAGEN 120 tablets — — FDA listed —
Fiber laxative 625 mg 53943-0147-27 Discount 90 tablets — — FDA listed —
Fibercon 625 mg 80070-0500-14 Foundation 140 tablets — — FDA listed —
Fiber Therapy 625 mg 49035-0147-94 Wal-Mart 140 tablets — — FDA listed —
Best Choice 625 mg 63941-0023-90 BEST 90 tablets — — FDA listed —
Fiber Caplets 625 mg 30142-0132-14 THE 140 tablets — — FDA listed —
Publix 625 mg 41415-0021-90 PUBLIX 90 tablets — — FDA listed —
Fiber Caps 625 mg 53041-0147-27 Guardian 90 tablets — — FDA listed —
Walgreen Fiber Lax 625 mg 00363-0120-14 WALGREENS 140 tablets — — FDA listed —
Fiber Laxative Caplets 625 mg 77333-0120-50 Gendose 50 tablets — — FDA listed —
Fiber Caplets 625 mg 21130-0021-40 SAFEWAY 140 tablets — — FDA listed —
Fiber Laxative 625 mg 36800-0465-27 Topco 90 tablets — — FDA listed —
Quality Choice Fiber Caplets 625 mg 83324-0276-14 QUALITY 140 tablets — — FDA listed —
up and up fiber therapy 625 mg 11673-0620-90 Target 140 tablets — — FDA listed —
Fiber Laxative 625 mg 41163-0147-94 UNITED 140 tablets — — FDA listed —
Fiber Lax 625 mg 55289-0949-30 PD-Rx 30 tablets — — FDA listed —
Fiber Laxative 625 mg 57896-0459-09 Geri-Care 90 tablets — — FDA listed —
Quality Choice 625 mg 63868-0530-90 QUALITY 90 tablets — — FDA listed —
Amazon Fiber Caplets 625 mg 72288-0201-40 AMAZON.COM 140 tablets — — FDA listed —
Meijer Fiber Caplets 625 mg 79481-1205-00 MEIJER 250 tablets — — FDA listed —
Rite Aid Fiber Caplets 625 mg 11822-2025-00 RITE 250 tablets — — FDA listed —
Calcium Polycarbophil 625 mg 58624-5003-01 SHANDONG 90 tablets — — FDA listed —
Premier Value 625 mg 68016-0220-25 PHARMACY 250 tablets — — FDA listed —
Calcium Polycarbophil 625 mg 69842-0846-02 CVS 250 tablets — — FDA listed —
Goodsense Fiber laxative 147 625 mg 50804-0147-94 GoodSense 140 tablets — — FDA listed —
Fibercon 625 mg 63029-0170-14 Medtech 140 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1986
On the market since
Nov 1986
📍
2026
Currently FDA-listed
40 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeRound
ImprintE
Size16 mm
ScoringNot scored
FlavorLemon
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII 2S7830E561
    Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients   citric acid, crospovidone, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sucralose

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerNUMARK BRANDS, INC
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code69846
First marketedNov 1986
Product typeHuman Otc Drug
Portfolio4 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 19 words ▾

Use for relief of occasional constipation and irregularity. This product generally produces bowel movement in 12 - 72 hours.

⏱️ Dosage and Administration 94 words ▾

Directions drink a full glass (8 fl. oz.) of liquid with each dose chew tablets thoroughly do not swallow tablets whole adults and children 12 years of age and over up to 8 tablets daily in divided doses of 2 tablets per dose children 6 to under 12 years of age up to 4 tablets daily in divided doses of 1 tablet per dose children 2 to under 6 years of age up to 2 tablets daily in divided doses of 1 tablet per dose children under 2 years of age consult a doctor

⚠️ Warnings 54 words ▾

Warnings Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

📦 Storage and Handling 15 words ▾

Other information each tablet contains calcium 125 mg store at room temperature avoid excessive humidity

🧪 Active Ingredient 11 words ▾

Active Ingredients Calcium polycarbophil 625 mg (equivalent to 500 mg polycarbophil)

🧪 Inactive Ingredients 13 words ▾

Inactive ingredients citric acid, crospovidone, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sucralose

🎯 Purpose 5 words ▾

Purpose Bulk for mixing Laxative

📄 Do Not Use 15 words ▾

Do not use this product for more than 1 week unless directed by a doctor

📄 Ask a Doctor Before Use If 24 words ▾

Ask a doctor before use if you have abdominal pain nausea vomiting a sudden change in bowel habits over a period of 2 weeks

📄 Ask a Doctor or Pharmacist Before Use If 44 words ▾

Ask a doctor or pharmacist before use if you are taking an antibiotic containing tetracycline as this product contains calcium taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.

📄 Stop Use and Ask a Doctor If 26 words ▾

Stop use and ask a doctor if rectal bleeding occurs you fail to have bowel movement after use of laxative. These may indicate a serious condition

🤰 If Pregnant or Breast-Feeding 23 words ▾

As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 2 words ▾

Questions? 1-800-331-0221

📄 Package Label / Principal Display Panel 124 words ▾

PRINCIPAL DISPLAY PANEL Equalactin ® Bulk Forming Laxative Relieves Symptoms of Nervous Stomach Irregularity Abdominal Discomfort Loose Bowels Constipation 48 CITRUS FLAVORED CHEWABLE TABLETS Nervous Stomach (similar to Irritable Bowel), with its symptoms of loose bowels, irregularity, abdominal discomfort and constipation, is caused by water imbalance in the bowel, and afflicts millions. Equalactin provides relief by equalizing the water balance to restore normal bowel movements. When you feel the onset of nervous stomach symptoms, take Equalactin to provide relief and prevent the episode from becoming severe.

Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing. Distributed by: Numark Brands 138 East Main Street, Suite 201 Kent, OH 44240 Rev 7/25 10001C EQ-48FC LOT: EXP:

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Equalactin Laxative (this brand).

Top reported reactions

Constipation89
Fall87
Hypotension77
Pain75
Cognitive Disorder73
Toxicity To Various Agents71
Balance Disorder70

Reporter sex

0 reports

Serious outcomes

Death44
Disabling8
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 97 14
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by NUMARK BRANDS, INC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 24 tablets (69846-0000-26). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
NUMARK BRANDS, INC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 69844-0115-01 · Graviti 69846-0110-42 · NUMARK →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.